Opko Health Inc. (NASDAQ:OPK) has market worth of 1.84B along 517.33M outstanding shares. The stock moved -1.11% to $3.55 in recent session. The recent traded volume was 3241571 shares. The stock had closed at $3.59 on the previous day.
Many Insiders have done trades inside the Opko Health Inc. (NASDAQ:OPK). The Company has disclosed insider trading transaction to the Securities and Exchange Commission (SEC). The FROST PHILLIP MD ET AL; CEO & Chairman of OPKO Health, Inc. acquired 25000 shares at value of $3.48 on 12 Mar 2018. The Insider selling transaction had a total value worth of $86995. After the buying activity, now FROST PHILLIP MD ET AL directly owns 2007300 shares of the company’s stock, valued at approximately $7125915. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing on 13 Mar 2018.
OPKO Health, Inc.’s insider FROST PHILLIP MD ET AL purchased 32000 shares of the stock in a negotiation that occurred on 08 Mar 2018. The stock was bought at an average cost of S 3.28 per share, for a total transaction worth of $ 104835. The Buy was disclosed in a legal filing with the Securities & Exchange Commission, on 09 Mar 2018.
In related news, Rubin Steven D Executive VP-Administration bought 6000 shares of the firm’s stock in a transaction that recorded on 07 Mar 2018. The stock was bought at an average price of $ 3.25 for a total value of $ 19500.
FROST PHILLIP MD ET AL CEO & Chairman at OPKO Health, Inc. also bought 75000 on 07 Mar 2018 at an average price of $ 3.29 for a total value of $ 246946. The disclosure for this transaction can be found in SEC Form 4 submitted on 08 Mar 2018. Additionally, FROST PHILLIP MD ET AL CEO & Chairman at the corporation bought 364800 shares for $ 1073716 in a single transaction on 02 Mar 2018.
The stock has recorded a weekly performance of 0.28% and monthly performance is -11.91%. Shares have moved -30.12% over the last quarter and changed -42.09% over the recent six months. The shares registered yearly performance at -55.35% and YTD move seen at -27.55%.
In terms of profitability, OPKO Health, Inc. has a gross margin of 41.90%, an operating margin of -26.20% and a net profit margin of -28.90%. Return on assets come to -11.40% and return on investment coming to -10.60% while Return on equity come to -15.10%.
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, and Mexico. The company’s Diagnostics segment operates Bio-Reference Laboratories, a clinical laboratory that offers laboratory testing services in the detection, diagnosis, evaluation, monitoring, and treatment of diseases.